Brokers  /  MONOVEX

MONOVEX

Severe riskForex / CFD broker
🇬🇧 United Kingdom · 1-2 years · since 2025-06-16 · Monovex
Unregulated
Visit site ↗
🛡️ Been scammed or can’t withdraw from MONOVEX? Our free assistant writes up your case and shows exactly what to do next →
🇺🇸
No sign that MONOVEX actively operates in your country (United States). If you were solicited from here, be extra cautious — it may be an unregulated approach or a clone.
75
Severe risk
Scam Risk Scoremonitored · 2026-07-28
Lower riskHigher risk
  • No verified regulatory license on file
  • Recently established — about 13 months old
  • Withdrawal complaints in ~200% of recent reviews
  • No verifiable website or social-media presence
How this score is calculated — view the open algorithm

A transparent weighted score from objective public data — each factor scored 0–100 (higher = riskier), combined by the weights below.

FactorScoreWeight
Regulation & licensing8535%
Company age7215%
Clone / impersonation012%
Withdrawal & exposure complaints2412%
Offshore registration108%
Transparency (site/info/social)7810%

Based on public regulatory records, industry databases and independent reviews (Trustpilot, Forex Peace Army). Exit Risk reflects recent negative momentum in real reviews. A risk estimate from public data, not a definitive legal judgment; brokers may request a correction.

Company
Legal nameMonovex
Headquarters🇬🇧 United Kingdom
Founded2025-06-16
Years operating1-2 years
Employees0
Official websitemonovex.com
Trading conditions
Avg execution speed0 ms
Avg slippage0
Swap rating
Trading cost rating
Monitored traders0
Monitored orders0
Funding & instruments
Deposit methods · --
Withdrawal methods · --
Instruments--
Registered address
40 Gracechurch Street, London EC3V 0BT, United Kingdom

Regulation & licenses · 0

No valid regulatory license found — high caution advised.

Account types · 7

AccountMax leverageMin. depositMin. spreadCommissionEA
PREMIUM --€500,000----
VIP --€1,000,000----
DIAMOND --€250,000----
PLATINUM --€100,000----
GOLD --€50,000----
SILVER --€25,000----
BRONZE --€10,000----

Review analysis AI

MONOVEX presents a severe risk profile due to its complete lack of regulatory oversight, extremely high minimum deposit requirements, and absence of publicly available information about its trading conditions. The broker's London registration does not equate to regulatory authorisation, and no licences from the FCA or any other authority have been confirmed. Given these factors, FXCanary strongly advises against depositing funds with MONOVEX until it provides verifiable regulatory credentials and transparent operational details.

Best for
  • Not suitable for any trader without verified regulation
Not for
  • Retail traders with limited capital
  • Traders seeking regulatory protection
  • Anyone requiring transparent information on instruments and costs
Period:
What users complain about
Where reviewers are from
Spain1

Real user reviews

Where MONOVEX operates

Based on its licenses and complaint records.

🇪🇸 Spain 1 complaint

Market presence: WikiFX SkyEye · complaints: our records · licensing: official registers. Where you’re accepted is set by the broker’s own terms — always confirm before depositing.

Similar brokers

About MONOVEX

Overview

MONOVEX is a brokerage entity registered in the United Kingdom, with an official domain of monovex.com. The company was founded on June 16, 2025, making it a very recent entrant to the financial services market. Its registered address is 40 Gracechurch Street, London EC3V 0BT, a location in the heart of the City of London financial district.

Despite its London registration, MONOVEX does not appear to hold any regulatory licence from the UK Financial Conduct Authority (FCA) or any other recognised regulatory body. This absence of regulatory oversight is a significant factor for potential clients to consider, as it means the broker is not subject to the standards of client protection, capital adequacy, or dispute resolution that regulated firms must adhere to.

Account Types and Minimum Deposits

MONOVEX offers seven distinct account tiers, each with a high minimum deposit requirement. These range from the BRONZE account, requiring €10,000, to the PREMIUM and VIP accounts, which require €500,000 and €1,000,000 respectively. The DIAMOND, PLATINUM, GOLD, and SILVER accounts sit in between, with minimum deposits of €250,000, €100,000, €50,000, and €25,000.

Notably, maximum leverage information is not provided for any account tier (shown as '--' in the available data). This omission, combined with the very high entry barriers, suggests MONOVEX is targeting high-net-worth individuals or institutional clients rather than retail traders with smaller capital. The account names (VIP, Diamond, etc.) are common in the FX/CFD industry but often signal a marketing focus on exclusivity.

Trading Instruments and Platform

At present, no specific information is available regarding the trading instruments offered by MONOVEX. The known facts list instruments as '--', and there is no mention of a trading platform (such as MetaTrader 4/5, cTrader, or a proprietary platform). This lack of detail makes it impossible to assess what markets—forex, indices, commodities, cryptocurrencies, or others—clients could trade.

Similarly, no information is provided on deposit and withdrawal methods, spreads, commissions, or any additional features like demo accounts, educational resources, or customer support channels. The absence of these fundamental details is a significant gap in the broker's public profile.

Regulatory and Risk Considerations

The most critical point for any prospective client is MONOVEX's unregulated status. As of its founding date, it holds no licence from any known financial authority. In the UK, firms offering financial services are generally required to be authorised by the FCA, especially if they handle client money or offer leveraged products. The absence of such authorisation raises serious questions about the safety of client funds and the broker's compliance with anti-money laundering and client asset segregation rules.

Furthermore, the FXCanary Scam Risk Score assigned to MONOVEX is 75 out of 100, categorised as 'Severe'. This score reflects the combination of very high minimum deposits, lack of regulatory oversight, and the overall opacity of the broker's operations. Traders are strongly advised to exercise extreme caution and conduct thorough due diligence before considering any engagement with MONOVEX.

Target Audience

Based on the account structure, MONOVEX appears to target a very specific, high-net-worth clientele. The minimum deposit of €10,000 for the entry-level BRONZE account is far above what most retail forex brokers require (often $100–$500). The highest tiers demand deposits equivalent to a significant investment portfolio. This positioning suggests MONOVEX may be aiming at accredited investors, family offices, or institutional clients who are accustomed to high-touch, bespoke services.

However, without regulatory oversight or a track record, even wealthy individuals should approach such an offering with caution. The lack of independent reviews or third-party verification further compounds the risks. For retail traders with smaller capital, MONOVEX is clearly not an accessible option.

Conclusion

MONOVEX is a newly established broker registered in the UK but lacking regulatory authorisation. Its account tiers cater exclusively to high-net-worth individuals, with minimum deposits starting at €10,000 and going up to €1,000,000. No details are available about trading instruments, platforms, or operational policies.

The combination of an unregulated status, very high entry barriers, and a severe risk score makes MONOVEX a highly speculative and potentially dangerous choice for any trader. Independent public information is extremely limited, and the broker's own website (monovex.com) would need to be scrutinised closely if it becomes operational. For now, the known facts paint a picture of a high-risk entity that should be avoided pending further verification.

Overview compiled by FXCanary from regulatory records and public data. full MONOVEX review